{
  "ticker": "CMPS",
  "company_name": "COMPASS Pathways Plc - American",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04739865",
      "title": "The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression",
      "start_date": "2020-08-10",
      "completion_date": "2021-10-14",
      "enrollment": 0,
      "sponsor": "COMPASS Pathways"
    },
    {
      "nct_id": "NCT04433858",
      "title": "An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression",
      "start_date": "2021-03-01",
      "completion_date": "2026-05-01",
      "enrollment": 0,
      "sponsor": "Sheppard Pratt Health System"
    },
    {
      "nct_id": "NCT04661514",
      "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Anorexia Nervosa",
      "start_date": "2021-05-01",
      "completion_date": "2022-06-10",
      "enrollment": 0,
      "sponsor": "University of California, San Diego"
    },
    {
      "nct_id": "NCT04656301",
      "title": "Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Body Dysmorphic Disorders",
      "start_date": "2021-02-26",
      "completion_date": "2022-11-02",
      "enrollment": 0,
      "sponsor": "New York State Psychiatric Institute"
    },
    {
      "nct_id": "NCT05481736",
      "title": "Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Anorexia Nervosa",
      "start_date": "2022-10-12",
      "completion_date": "2024-11-18",
      "enrollment": 0,
      "sponsor": "COMPASS Pathways"
    },
    {
      "nct_id": "NCT05624268",
      "title": "Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Treatment Resistant Depression",
      "start_date": "2023-01-19",
      "completion_date": "2026-04",
      "enrollment": 0,
      "sponsor": "COMPASS Pathways"
    },
    {
      "nct_id": "NCT03775200",
      "title": "The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression",
      "start_date": "2019-03-01",
      "completion_date": "2021-09-27",
      "enrollment": 0,
      "sponsor": "COMPASS Pathways"
    },
    {
      "nct_id": "NCT05220410",
      "title": "The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression, Suicidal Ideation",
      "start_date": "2022-03-28",
      "completion_date": "2025-05-12",
      "enrollment": 0,
      "sponsor": "Sheppard Pratt Health System"
    },
    {
      "nct_id": "NCT06247839",
      "title": "The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2024-09-10",
      "completion_date": "2026-06-30",
      "enrollment": 0,
      "sponsor": "Sharmin Ghaznavi"
    },
    {
      "nct_id": "NCT05711940",
      "title": "Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Treatment Resistant Depression",
      "start_date": "2023-02-14",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "COMPASS Pathways"
    }
  ],
  "summary": {
    "total_trials": 24,
    "by_phase": {
      "PHASE2": 12,
      "PHASE3": 3,
      "": 1,
      "NA": 3,
      "PHASE1, PHASE2": 2,
      "PHASE1": 2,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 12,
      "ACTIVE_NOT_RECRUITING": 5,
      "RECRUITING": 3,
      "WITHDRAWN": 1,
      "UNKNOWN": 2,
      "TERMINATED": 1
    },
    "active_trials": 8,
    "completed_trials": 12,
    "conditions": [
      "Anorexia Nervosa",
      "Back Pain",
      "Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer, Ampullary Cancer",
      "Body Dysmorphic Disorders",
      "Doping in Sport, Performance Enhancing Product Use",
      "Locally Advanced Solid Tumor, Metastatic Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Mesothelioma, Melanoma, Head and Neck Cancer",
      "Major Depressive Disorder",
      "Metastatic Biliary Tract Cancer",
      "Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer",
      "Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma, Head and Neck Squamous Cell Carcinoma, Malignant Melanoma",
      "P1b: Advanced Solid Tumors, P2: Biliary Tract Cancer",
      "Post Traumatic Stress Disorder",
      "Suicidality",
      "Treatment Resistant Depression",
      "Treatment Resistant Depression, Suicidal Ideation",
      "Treatment-Resistant Major Depressive Disorder"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:32.600768",
    "search_query": "COMPASS Pathways Plc - American",
    "url": "https://clinicaltrials.gov/search?term=COMPASS+Pathways+Plc+-+American"
  }
}